Dr Ling Li's team devises new therapeutic strategies targeting tumour-associated immune landscape, stroma and vasculature.
Dr Ling Li leads the Tumour Microenvironment and Pharmacology Team, and is a member of the Centre for Cancer Drug Discovery. She has considerable experience of fit-for-purpose tumour model development gained from her experience in both academia and the pharmaceutical industry.